Phase I/II study of a combination of capecitabine, cisplatin, and intraperitonealdocetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis

被引：0
|
作者：
Cho, Hyungwoo
Ryu, Min-Hee
Yoo, Changhoon
Ryoo, Baek-Yeol
Park, Sook Ryun
Kim, Kyu-Pyo
Kim, Beom Su
Yoo, Moon-Won
Yook, Jeong Hwan
Kim, Byung Sik
Kang, Yoon-Koo
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[5] Asan Med Ctr, Dept Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
    Hyungwoo Cho
    Min-Hee Ryu
    Kyu-pyo Kim
    Baek-Yeol Ryoo
    Sook Ryun Park
    Bum Soo Kim
    In-Seob Lee
    Hee-Sung Kim
    Moon-Won Yoo
    Jeong Hwan Yook
    Seong Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Gastric Cancer, 2017, 20 : 970 - 977
  • [2] Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
    Cho, Hyungwoo
    Ryu, Min-Hee
    Kim, Kyu-pyo
    Ryoo, Baek-Yeol
    Park, Sook Ryun
    Kim, Bum Soo
    Lee, In-Seob
    Kim, Hee-Sung
    Yoo, Moon-Won
    Yook, Jeong Hwan
    Oh, Seong Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    GASTRIC CANCER, 2017, 20 (06) : 970 - 977
  • [3] A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer
    Cho, EK
    Lee, WK
    Im, SA
    Lee, SN
    Park, SH
    Bang, SM
    Park, DK
    Park, YH
    Shin, DB
    Lee, JH
    ONCOLOGY, 2005, 68 (4-6) : 333 - 340
  • [4] Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer
    Oh, Do-Youn
    Doi, Toshihiko
    Shirao, Kuniaki
    Lee, Keun-Wook
    Park, Sook Ryun
    Chen, Ying
    Yang, Liqiang
    Valota, Olga
    Bang, Yung-Jue
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 687 - 696
  • [5] Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP plus IP DOC trial.
    Fukushima, Ryoji
    Ishigami, Hironori
    Miwa, Hiroto
    Imano, Motohiro
    Kobayashi, Daisuke
    Tsuji, Yasushi
    Hidemura, Akio
    Kusumoto, Tetsuya
    Omori, Takeshi
    Yabusaki, Hiroshi
    Ohashi, Norifumi
    Ota, Mitsuhiko
    Yamaguchi, Hironori
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
    Yun, Jina
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 885 - 891
  • [7] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [8] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [9] Phase II study of trastuzumab in combination with capecitabine and oxaliplatin in patients with advanced gastric cancer
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Young Soo
    Park, Sook Ryun
    Kim, Jong Gwang
    Han, Hye-Suk
    Chung, Ik-Joo
    Song, Eun-Kee
    Lee, Kyung Hee
    Kang, Seok Yun
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [10] Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
    J H Baek
    J G Kim
    S B Jeon
    Y S Chae
    D H Kim
    S K Sohn
    K B Lee
    Y J Choi
    H J Shin
    J S Chung
    G J Cho
    H Y Jung
    W Yu
    British Journal of Cancer, 2006, 94 : 1407 - 1411
12345